Latest Market News

Aquirian Limited has secured a $2.3 million strategic placement with Topgroup and signed a non-binding Memorandum of Understanding to form Drillforce WA, a 50 – 50 joint venture combining their drilling and blasting expertise.

Ardea Resources has extended its Major Project Status for the Kalgoorlie Nickel Project, reinforcing its strategic role in Australia's critical minerals sector and ensuring continued government support.

Infratil Limited is expanding its footprint in New Zealand's energy sector by acquiring an additional 4.92% stake in Contact Energy for NZ$437.7 million, combining debt and equity financing.

Vectus Biosystems has had its ASX trading suspension lifted following the disclosure of a significant transaction involving a compound from its drug library, signaling renewed investor interest.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

Shriro Holdings announces a $5 million off-market share buy-back at a 14.1% premium, signaling a pivot from acquisitions to expanding its BBQ range globally. The move aims to return excess capital to shareholders while maintaining flexibility for further buy-backs.

DGL Group Limited remains suspended from ASX trading following delays in lodging audited accounts and a concerning auditor disclaimer. Investors await clarity on the company’s financial health and path to reinstatement.

Vault Minerals Limited has announced a significant security consolidation, reducing its ordinary shares and performance rights by a factor of more than six. The move, effective from mid-November, aims to streamline the company’s capital structure ahead of resumed trading.

Aspermont Limited has completed its Share Purchase Plan and shortfall placement, raising over A$1 million to fund its digital transformation and AI-driven services expansion.

DGL Group Limited has reported a larger-than-expected FY25 net loss following an increased goodwill impairment and received a Disclaimer of Opinion from its auditor due to inventory and control issues during a major ERP system rollout.

FortifAI Limited reported steady revenue and significant cost reductions in Q1 FY26, while securing new contracts and advancing AI initiatives to boost operational efficiency.

Zoono Group Limited has responded to an ASX price query following a recent surge in its share price and trading volume, confirming no undisclosed information exists and attributing market activity to ongoing shelf-life extension trials across multiple continents.